Jika mau, Anda dapat mengirim electronic mail kepada kami dengan deskripsi mendetail tentang masalah Anda atau menelusuri bagian FAQ yang komprehensif kami mendapatkan jawaban instan.Unfit clients even have the choice of venetoclax as well as obinutuzumab (VO) as frontline therapy. This is based on a stage III trial that compared VO with ClbO in el